A Pilot Study of OncoSil™ Given to Patients With Pancreatic Cancer Treated With Gemcitabine +/- Nab-paclitaxel.
Clinical trial NCT03076216 · COMPLETED
Trial details
- NCT number
- NCT03076216
- Sponsor
- OncoSil Medical Limited
- Status
- COMPLETED
- Phase
- Not Applicable
- Study type
- INTERVENTIONAL
- Start date
- 2017-08-01
- Primary completion
- 2020-11-28
- Enrollment
- 9
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.